Hugo Award nominee 1986, Nebula Award nominee 1985.
Genetron was being very careful. The firm had succeeded where others had failed, combining
protein molecular circuitry with silicon electronics to create
programmable, medically applicable biochips, or MABs. It was the first
useful useful product of the biochip revolution, and any bad press would jeopardize all they'd accomplished.
Brilliant and eccentric, Vergil
Ulam had been working on the project for nearly three years and had
recognized Genetron's shortsightedness: Why limit oneself to silicon and amino acid biochips when a single mammalian cell had the DNA capacity
to store huge amounts of information? The idea fascinated him, and the
fact that no one else at Genetron had made the connection was a source
of deep satisfaction, since it left him free to use the company's labs
for private research.
Using his own white blood cells, Vergil had
actually developed lymphocytes with an ability to learn... to think... and to pass the learning on to other cells. Then the roof fell in. Somehow
Genetron discovered his secret computer file - just the sort of thing
that, if leaked, could ruin the firm's position in the marketplace. He
was ordered to destroy his research, or face not only dismissal but also industry-wide blacklisting. Yet he had come too far to simply throw it
all away.
So Vergil made a fateful decision: he injected the
altered cells into his bloodstream. And what followed was nothing short
of a miracle: bizarre physical changes that scared him at first, then
enthralled him... increasingly sophisticated communications from the
intelligent micro-organisms he'd created, like music in his blood.
The transformation had begun.